Bronquiolitis Obliterante como secuela de infección por Adenovirus. Presentación de caso, Hospital Infantil Dr. Robert Reid Cabral
Date
Subject
bronchiolitis obliterans
adenovirus
neumology
ground glass
wheezing
postinfectious
bronquiolitis obliterante
adenovirus
neumología
vidrio esmerilado
sibilantes
postinfecciosa
adenovirus
neumology
ground glass
wheezing
postinfectious
bronquiolitis obliterante
adenovirus
neumología
vidrio esmerilado
sibilantes
postinfecciosa
Language:
Journal Title
Journal ISSN
Volume Title
Publisher
Intituto Tecnológico de Santo Domingo (INTEC)
Los procesos pulmonares en menores de dos años son causados en su mayoría por agentes virales, los cuales, en gran parte, se resuelven sin complicaciones posteriores. Sin embargo, hay agentes causales que debemos tener presentes puesto que pueden dejar secuelas importantes a nivel pulmonar. A continuación, presentamos un caso de bronquiolitis obliterante como secuela de infección por adenovirus.
Pulmonary processes in children under two years are mostly caused by viral agents, which are largely resolved without further complications, however there are causal agents that we must keep in mind that can leave important sequelae at the lungs. We present a case of Bronchiolitis Obliterans as sequel of Adenovirus infection.
Pulmonary processes in children under two years are mostly caused by viral agents, which are largely resolved without further complications, however there are causal agents that we must keep in mind that can leave important sequelae at the lungs. We present a case of Bronchiolitis Obliterans as sequel of Adenovirus infection.
Description
Type
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
info:eu-repo/semantics/publishedVersion
Source
Science and Health; Vol 4 No 2 (2020): Science and Health, may-August; 109-114
Ciencia y Salud; Vol. 4 Núm. 2 (2020): Ciencia y Salud, mayo-agosto; 109-114
2613-8824
2613-8816
10.22206/cysa.2020.v4i2
Ciencia y Salud; Vol. 4 Núm. 2 (2020): Ciencia y Salud, mayo-agosto; 109-114
2613-8824
2613-8816
10.22206/cysa.2020.v4i2